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3. As for the testing procedure, we indeed used datasets
non-overlapping with those upon which the training
was run; this is necessary to avoid unwanted biases.
Furthermore, as described in Dal Moro et al.2 we chose
a number of non-intersecting training/testing sets by
properly ‘shuffling’ the whole data set, and took
averages of the results, thus validating the model.
4. The above canonical procedure has been performed
also for the logistic regression and support vector
machine algorithms, modulo the differences in struc-
ture, in the entity and number of parameters
considered, and in the training scheme employed for
the particular methodology. The collection of results
are finally compared in Dal Moro et al.2 Figure 1.
In conclusion, although we understand that for special
problems the ANN may still yield reasonable results, we
argue that in general (from a theoretical perspective) and
in particular (for the considered case study) support vector
machine indeed outperform ANN.
1. Tonello L. Support vector machines versus artificial neural network: who
is the winner? Kidney Int 2006 (in press).
2. Dal Moro F, Abate A, Lanckriet GRG et al. A novel approach for accurate
prediction of spontaneous passage of ureteral stones: support vector
machines. Kidney Int 2006; 69: 157–160.
A Abate1, F Dal Moro2 and GRG Lanckriet3
1Department of EECS, University of California, Berkeley, California, USA;
2Department of Urology, University of Padova, Padova, Italy and
3Electrical and Computer Engineering, University of California, San Diego,
California, USA
Correspondence: A Abate, Department of EECS, University of California,
Berkeley, California, USA. E-mail: aabate@eecs.Berkeley.edu
On Kidney International editorial
Evidence-based politics of salt and
blood pressure?
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To the Editor: Your editorial ‘Evidence-based politics of
salt and blood pressure’1 distorts both the scientific debate
among leading experts and contains significant factual errors
about the Salt Institute and our Data Quality Act challenge in
Salt Institute v. Leavitt.
You accuse the Salt Institute of having ‘invent(ed)
controversy’ on the question of whether the entire population
should be advised to reduce dietary salt. The Cochrane
Collaboration, the prestigious consortium of medical scien-
tists who invented and defined the practice of ‘evidence-
based medicine,’ rejects the evidence for a population
intervention.2 The current president of the International
Society of Hypertension rejects a ‘one size fits all’ approach.3
The founder of the American Society of Hypertension, a Time
magazine cover story subject for his seminal research, rejects
the idea that evidence justifies universal salt reduction.4 In
1998, investigative reporter Gary Taubes won the national
prize from the National Association of Science Writers for his
article in Science on ‘The (political) science of salt’5
chronicling National Heart, Lung and Blood Institute’s
efforts to quell scientific dissent. We did not ‘invent’ this
controversy among leading medical researchers.
You discuss our lawsuit, Salt Institute v. Leavitt, which
we brought jointly with the US Chamber of Commerce,
speculating disparagingly: ‘Their aim is probably to extract
data on a few patients and show that these few did not
respond to decreased salt intake with lowering blood
pressure.’ Utter nonsense. Our petition6 sought correction
of a statement by the National Heart, Lung and Blood
Institute that the DASH-Sodium study proved that every
American would benefit from lowering dietary salt. We
simply sought basic statistics, no patient data. Most scientists
would agree with us that the statistics we sought – blood
pressure means and standard deviations – are necessary to
interpret the findings, yet these have yet to be produced
5 years after the first report was published, despite a flood
of other published articles, one admitting that there is
no statistically significant association in six of the eight
subgroups.7 As the government intended to use the study to
support the Dietary Guidelines for Americans, the question is
clearly important. The government should meet the same
standards of scientific justification as private parties. And as
we have seen in the Vioxx debacle, even the higher private
sector standard may not be high enough.
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To the Editor: The editorial on the politics of salt and blood
pressure was exceptionally prescient in recognizing the
influence of a trade lobby, the Salt Institute, on policies
(Kidney Int 2006; 69: 1707–1708). In one regard, though, the
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editorial conveyed a common misconception: that current
levels of salt are necessary for preservative functions.
We have analyzed the sodium contents of competing
brands within the same category of foods.1 In most categories
we found wide variations. For instance, Johnsonville Original
breakfast links (sausages) contain twice as much sodium as
Jimmy Dean Pork Original links (1110 mg vs 570 mg).
Banquet macaroni and cheese frozen dinner has twice as
much sodium as Stouffer’s Lean Cuisine macaroni and cheese
dinner (440 mg vs 230 mg). Those comparisons prove that
many companies could greatly reduce sodium levels without
endangering health or consumer acceptance.
Although the Salt Institute embraces the Data Quality Act,
it fears the Food, Drug, and Cosmetic Act. That law requires
that substances in food be restricted to safe levels. However,
salt is considered by the US Food and Drug Administration
to be ‘generally recognized as safe’, which means that levels
cannot be restricted.2 The Center for Science in the Public
Interest in 1978 petitioned the Food and Drug Administra-
tion to revoke the generally recognized as safe status and limit
salt, especially in the biggest sources of sodium. (The US
Department of Agriculture should do the same for meat and
poultry products.) After the Food and Drug Administration
failed to take action, Center for Science in the Public Interest
sued the Food and Drug Administration (unsuccessfully) in
1982 and 2005, and later in 2005 again petitioned the agency
to protect the public health.
Halving sodium levels in packaged and restaurant
foods could save 150 000 lives per year.3 It is unfortunate
that government health authorities have not shown the
will to act.
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To the Editor: The Editorial by Al-Awqati1 mentioned some
of the serious flaws in the controversial findings of Michael
Alderman. In March 2006, a national Australian radio
program was flooded with letters from grateful patients
who had abandoned their low-salt diets after hearing an
alarming interview with Michael Alderman about salt and
heart attacks.2 What makes Alderman the Salt Institute’s hero
is that his flawed work is worth so many millions of dollars to
the salt industry worldwide.
Alderman has been a consultant to the Salt Institute
for years but continually denies any conflict of interest
and describes himself as unpaid, even after revealing that
the Institute has paid him several thousand dollars.3
Theoretically, conflict of interest cannot alter objective
data, nevertheless the real world takes less notice of a
report that butter is harmless if the dairy industry funds the
study.
The salt consensus is now so massive that lonely sceptics
seem to get a voice as Devil’s Advocates even with flawed
data. Editors and referees should ask more carefully who the
sceptics are writing for – colleagues who expect good data, or
the Salt Institute’s Medical Advisory Board, which helps it to
preserve the illusion of controversy.
Alderman’s flawed report damages public health severely
worldwide. Medical journals should pay more attention to
the need for impeccable quality in an alarming report,
bearing in mind that the media will give it special attention
and disseminate it widely.
1. Al-Awqati Q. Evidence-based politics of salt and blood pressure. Kidney
Int 2006; 10: 1707–1708.
2. www.saltmatters.org (Newsletter 140, accessed 3 July 2006).
3. Alderman MH. Universal recommendations for sodium intake should be
avoided [letter]. Med J Aust 1999; 171: 163.
TC Beard1
1Menzies Research Institute, University of Tasmania, Hobart, Australia
Correspondence: TC Beard, Menzies Research Institute, Private Bag 23, GPO
HOBART TAS 7001, Hobart, Tasmania, Australia.
E-mail: trevor.beard@utas.edu.au
86 Kidney International (2007) 71, 83–86
l e t t e r t o t h e e d i t o r
